Pandemic-era favorites such as Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) will be under scrutiny after President Donald Trump on Monday urged the companies to justify the success of their COVID-19 ...
Moderna (NASDAQ:MRNA) stock is jumping again. Shares are up 9% today, trading near $57 in the Tuesday afternoon session. That ...
Pfizer (NYSE:PFE | PFE Price Prediction) and Moderna (NASDAQ:MRNA) just closed the books on Q4 2025, and the contrast is striking. Pfizer leaned on a diversified non-COVID portfolio and a fresh push ...
The smaller, more volatile of these two companies has higher potential for significant gains. However, that also comes with a healthy dose of risk. Choosing between these two stocks may come down to ...
Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively, Friday after a report that the Trump administration plans to link the deaths of 25 children to COVID vaccines. Trump health officials ...
Pfizer and BioNTech plan to begin distributing their updated shot "immediately," the partners said in a release. (UCG/Getty Images) Amid uncertainty over how the Trump administration would approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results